These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31559009)

  • 1. Targeting viral entry as a strategy for broad-spectrum antivirals.
    Mazzon M; Marsh M
    F1000Res; 2019; 8():. PubMed ID: 31559009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry.
    Mazzon M; Ortega-Prieto AM; Imrie D; Luft C; Hess L; Czieso S; Grove J; Skelton JK; Farleigh L; Bugert JJ; Wright E; Temperton N; Angell R; Oxenford S; Jacobs M; Ketteler R; Dorner M; Marsh M
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30791609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
    Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry.
    Lin LT; Chen TY; Lin SC; Chung CY; Lin TC; Wang GH; Anderson R; Lin CC; Richardson CD
    BMC Microbiol; 2013 Aug; 13():187. PubMed ID: 23924316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad-spectrum Respiratory Virus Entry Inhibitors.
    Zhao H; Yuen KY
    Adv Exp Med Biol; 2022; 1366():137-153. PubMed ID: 35412139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel entry inhibitors targeting emerging viruses.
    Zhou Y; Simmons G
    Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1129-38. PubMed ID: 23199399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses.
    Lu S; Pan X; Chen D; Xie X; Wu Y; Shang W; Jiang X; Sun Y; Fan S; He J
    Bioorg Chem; 2021 Feb; 107():104619. PubMed ID: 33450541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the development of entry inhibitors for sialic-acid-targeting viruses.
    Heida R; Bhide YC; Gasbarri M; Kocabiyik Ö; Stellacci F; Huckriede ALW; Hinrichs WLJ; Frijlink HW
    Drug Discov Today; 2021 Jan; 26(1):122-137. PubMed ID: 33099021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad-spectrum antivirals against viral fusion.
    Vigant F; Santos NC; Lee B
    Nat Rev Microbiol; 2015 Jul; 13(7):426-37. PubMed ID: 26075364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies.
    Seyedpour S; Khodaei B; Loghman AH; Seyedpour N; Kisomi MF; Balibegloo M; Nezamabadi SS; Gholami B; Saghazadeh A; Rezaei N
    J Cell Physiol; 2021 Apr; 236(4):2364-2392. PubMed ID: 32901936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membrane.
    Oeyen M; Meyen E; Noppen S; Claes S; Doijen J; Vermeire K; Süssmuth RD; Schols D
    Virology; 2021 Oct; 562():74-86. PubMed ID: 34274562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor.
    Chou YY; Cuevas C; Carocci M; Stubbs SH; Ma M; Cureton DK; Chao L; Evesson F; He K; Yang PL; Whelan SP; Ross SR; Kirchhausen T; Gaudin R
    J Virol; 2016 May; 90(9):4494-4510. PubMed ID: 26912630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of viral and cellular factors on flavivirus entry.
    Cordero-Rivera CD; De Jesús-González LA; Osuna-Ramos JF; Palacios-Rápalo SN; Farfan-Morales CN; Reyes-Ruiz JM; Del Ángel RM
    Curr Opin Virol; 2021 Aug; 49():164-175. PubMed ID: 34171540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.
    Krepstakies M; Lucifora J; Nagel CH; Zeisel MB; Holstermann B; Hohenberg H; Kowalski I; Gutsmann T; Baumert TF; Brandenburg K; Hauber J; Protzer U
    J Infect Dis; 2012 Jun; 205(11):1654-64. PubMed ID: 22457281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A broad-spectrum antiviral targeting entry of enveloped viruses.
    Wolf MC; Freiberg AN; Zhang T; Akyol-Ataman Z; Grock A; Hong PW; Li J; Watson NF; Fang AQ; Aguilar HC; Porotto M; Honko AN; Damoiseaux R; Miller JP; Woodson SE; Chantasirivisal S; Fontanes V; Negrete OA; Krogstad P; Dasgupta A; Moscona A; Hensley LE; Whelan SP; Faull KF; Holbrook MR; Jung ME; Lee B
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3157-62. PubMed ID: 20133606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of singlet oxygen generated by a broad-spectrum viral fusion inhibitor on membrane nanoarchitecture.
    Hollmann A; Gonçalves S; Augusto MT; Castanho MA; Lee B; Santos NC
    Nanomedicine; 2015 Jul; 11(5):1163-7. PubMed ID: 25791807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses.
    Tampere M; Pettke A; Salata C; Wallner O; Koolmeister T; Cazares-Körner A; Visnes T; Hesselman MC; Kunold E; Wiita E; Kalderén C; Lightowler M; Jemth AS; Lehtiö J; Rosenquist Å; Warpman-Berglund U; Helleday T; Mirazimi A; Jafari R; Puumalainen MR
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33322045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism.
    Bottom-Tanzer SF; Rybkina K; Bell JN; Alabi CA; Mathieu C; Lu M; Biswas S; Vasquez M; Porotto M; Melero JA; Más V; Moscona A
    mBio; 2019 Feb; 10(1):. PubMed ID: 30782664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo.
    Kumar N; Taily IM; Singh C; Kumar S; Rajmani RS; Chakraborty D; Sharma A; Singh P; Thakur KG; Varadarajan R; Ringe RP; Banerjee P; Banerjee I
    PLoS Pathog; 2023 May; 19(5):e1011358. PubMed ID: 37126530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of brevinin-1EMa-derived stapled peptides as broad-spectrum virus entry blockers.
    Kim MI; Pham TK; Kim D; Park M; Kim BO; Cho YH; Kim YW; Lee C
    Virology; 2021 Sep; 561():6-16. PubMed ID: 34089997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.